Evidence map›Paper›PMID 42903958›Full record

ReviewhLife2024

Fecal microbiota transplantation in clinical practice: Present controversies and future prospects.

Hongliang Tian, Xinjun Wang, Zhixun Fang, Long Li, Chunyan Wu, Dexi Bi, Ning Li, Qiyi Chen, Huanlong Qin

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in hLife, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hongliang TianDepartment of Colorectal Disease, Tenth People's Hospital of Tongji University, Shanghai, China.
Xinjun WangDepartment of Colorectal Disease, Tenth People's Hospital of Tongji University, Shanghai, China.
Zhixun FangDepartment of Colorectal Disease, Tenth People's Hospital of Tongji University, Shanghai, China.
Long LiDepartment of Colorectal Disease, Tenth People's Hospital of Tongji University, Shanghai, China.
Chunyan WuShanghai Institution of Gut Microbiota Research and Engineering Development, Tenth People's Hospital of Tongji University, Shanghai, China.
Dexi BiDepartment of Pathology, Tenth People's Hospital of Tongji University, Shanghai, China.
Ning LiDepartment of Colorectal Disease, Tenth People's Hospital of Tongji University, Shanghai, China.
Qiyi ChenDepartment of Colorectal Disease, Tenth People's Hospital of Tongji University, Shanghai, China.
Huanlong QinDepartment of Colorectal Disease, Tenth People's Hospital of Tongji University, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The gut microbiota, serving as the only "organ" that humans can share, has been extensively applied in the treatment of various intestinal and extraintestinal diseases through fecal microbiota transplantation (FMT) technology. By optimizing the donor selection strategy, FMT exhibited the highest effectiveness (more than 90%) in treating acute intestinal inflammations, such as recurrent

Indexed as

clinical researchcolonization antagonismfecal microbiota transplantation

Identifiers

PMID42903958
PMCPMC13681575

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.